Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study. Aomar Millán, I. Salvatierra, Juan Torres Parejo, Úrsula Faro-Miguez, Naya Callejas Rubio, José Luis Ceballos Torres, Ángel Cruces Moreno, María Teresa Gómez Jiménez, Francisco Javier Hernández Quero, José Anguita-Santos, F. 2025-01-28T11:25:53Z 2025-01-28T11:25:53Z 2021-06 journal article Aomar-Millán IF, Salvatierra J, Torres-Parejo Ú, Faro-Miguez N, Callejas-Rubio JL, Ceballos-Torres Á, Cruces-Moreno MT, Gómez-Jiménez FJ, Hernández-Quero J, Anguita-Santos F. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study. Intern Emerg Med. 2021 Jun;16(4):843-852. doi: 10.1007/s11739-020-02600-z. (IF: 3.4; Q2) https://hdl.handle.net/10481/100739 10.1007/s11739-020-02600-z http://creativecommons.org/licenses/by-nc-nd/4.0/ open access Attribution-NonCommercial-NoDerivatives 4.0 Internacional